Search Results
Mar 30, 2026, 17:36 ET LG Electronics celebra 30 anos de Brasil com arte, música e inovação
para o futuro, ela convida o público para um K-Pop Dance-Off no Parque Villa Lobos, em São Paulo. A experiência cultural única visa conectar o DNA inovador da LG à energia empolgante e ao estilo de vida dos Gen Z e Millennials. Fortemente alinhada à Hallyu, fenômeno cultural sul-coreano
More news about: LG Electronics Brasil
Mar 30, 2026, 16:19 ET Grammy-Winner Eric Bellinger Launches on Passes With Birthday Bash and New Single Release
Don't Want Her" ft. Problem. As the grandson of Bobby Day, the legendary songwriter behind "Rockin' Robin," music and creative ownership run deep in his DNA.That instinct for ownership is exactly what brought him to Passes.Why Are Musicians Joining the Creator Economy Through Passes?Musicians
More news about: Passes
Mar 30, 2026, 14:17 ET Mphasis and Flagstar Bank Mark Major Milestone by Completing First Phase of Modernizing the Bank's Technology Infrastructure
while supporting Flagstar's future growth.About MphasisAt Mphasis, engineering has been in our DNA since inception.Mphasis is an AI‑led, platform‑driven company with human‑in‑the‑loop intelligence, helping global enterprises modernize,
More news about: Mphasis
Mar 30, 2026, 12:34 ET Skyhawk Therapeutics Announces its Founding Scientific Advisory Board Chairman Receives the American Cancer Society's 2026 Medal of Honor
detection can be improved. In his MIT lab, Dr. Jacks and his group study how key genes, including tumor suppressors, oncogenes, and genes related to DNA repair, help cancers resist treatment and promote growth. Dr. Jacks has also conducted extensive research into how the immune system sees and also fails
More news about: Skyhawk Therapeutics
Mar 30, 2026, 11:06 ET Hoverfly Technologies Enters Drone Components Industry with "Hoverfly Motors - Powered by KRM"
Hoverfly's transition into components provides the broader industry with a "Blue-DNA" hardware alternative to restricted foreign technology."We are not exporting parts; we are transplanting our most advanced robotics DNA into the American defense ecosystem," added Kwang-sik Park, CEO of KRM. "By
More news about: Hoverfly Technologies Inc.
Mar 30, 2026, 10:53 ET TCC Appoints New Executive Vice President of Sales; Announces Strategic District Realignment to Support Continued Growth
400 communities, actively invests in local and national causes. Community giveback initiatives are a core part of Round Room and each of its entities' DNA as the company regularly organizes events that leave positive impacts on the communities it serves. On a larger, national scale, they host quarterly
More news about: TCC
Mar 30, 2026, 08:37 ET Nature Trust Press Announces New Manifesto Challenging Modern Nutrition, Accepted into Library of Congress After 16-Year Scientific Inquiry
vegan lifestyle. Much of this science, I wasn't even aware of."By documenting the chemical and biological impact of living foods on human DNA, Axay Shah moves the conversation beyond simple dieting and into the realm of cellular healing.A Global Movement for "Cellular Home" In
More news about: Nature Trust Press
Mar 30, 2026, 08:00 ET PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Company issued $30 million in Series D warrants, which are callable upon the publication of a draft CMS coverage policy for Lucid's EsoGuard Esophageal DNA Test.PAVmed relaunched its medical device portfolio and appointed industry veteran Joseph Virgilio as Chief Business Officer of Medical Devices
More news about: PAVmed Inc.
Mar 30, 2026, 07:01 ET Korean Patent Office Grants Acurx Pharmaceuticals New Patent for DNA Polymerase IIIC Inhibitors
candidates with a Gram-positive selective spectrum (GPSS®) that blocks the active site of the Gram-positive specific bacterial enzyme DNA polymerase IIIC (pol IIIC), inhibiting DNA replication and leading to Gram-positive bacterial cell death. Its R&D pipeline includes antibiotic product candidates that
More news about: Acurx Pharmaceuticals, Inc.
Mar 30, 2026, 06:00 ET IDEAYA Biosciences Announces First-Patient-In for Phase 1 Combination Study of IDE849, DLL3 TOP1 ADC, and IDE161, PARG Inhibitor, in DLL3 Upregulated Solid Tumor Indications, including SCLC, NETs, NECs, and Melanoma
chains generated by PARP during the DNA damage response, leading to persistent PARylation and impaired resolution of DNA repair complexes. Together with TOP1-payload ADCs, this unique mechanism-of-action results in sustained TOP1 cleavage complexes and the accumulation of DNA damage that delivers enhanced
More news about: IDEAYA Biosciences, Inc.
Mar 30, 2026, 01:33 ET WuXi Biologics Honored with CDMO Leadership Awards for Ninth Consecutive Year
technology platforms, deep accumulated know‑how in molecule and process development, and a leading global quality system, WuXi Biologics' timelines from DNA to IND and from IND to BLA have been shortened to 6 months and 15 months, respectively, compared with industry averages of 10–12 months and 24–36 months.
More news about: WuXi Biologics
Mar 27, 2026, 10:01 ET Human Identification Market worth $1.69 billion by 2031 | MarketsandMarkets™
North American human identification market is driven by increasing public-private investments in the forensic science industry, rising awareness of DNA testing technology and its application among forensic experts, growing technological advancements in forensic equipment, and the presence of major market
More news about: MarketsandMarkets
Mar 27, 2026, 09:00 ET TENEO EXPANDS GLOBAL POLITICAL RISK ADVISORY BUSINESS
events and in media as well as contribute to Teneo's thought leadership."Geopolitical risk and government relations is in our DNA as a firm. It is also in the DNA of global markets and corporate strategy. Never more so than today," said Paul Keary, CEO of Teneo. "In this environment
More news about: Teneo
Mar 27, 2026, 09:00 ET Mastering the Ground: MAMMOTION Redefines Precision in Modern Outdoor Living
prestigious tournaments is a natural fit for us," said Jayden Wei, CEO of MAMMOTION. "Tennis demands the highest standards of precision—a value that is in our DNA. We want to inspire people to take back control of their space and discover a more effortless way of Lifestyle in Motion."About MAMMOTIONMAMMOTION
More news about: MAMMOTION
Mar 26, 2026, 12:50 ET National Cancer Institute Awards Rosalind Franklin University Researcher Grant to Crack the Epigenetic Code of Pancreatic Cancer Muscle Wasting
embodies the spirit of inquiry and excellence modeled by its namesake Dr. Rosalind Franklin, whose Photo 51 was crucial to solving the structure of DNA. Recognized for its research in the areas of neuroscience, brain related diseases, inherited disorders, diabetes, obesity, and gait and balance, the
More news about: Rosalind Franklin University of Medicine and Science
Mar 26, 2026, 10:15 ET Global Food & Beverage Industry Outlook 2030- Exclusive Report by MarketsandMarkets™
platforms for convenience.By 2030, personalized nutrition is expected to be part of everyday food systems. Companies will create products shaped by DNA profiles, gut health data, and lifestyle habits. Food technology will also move forward, making lab-grown meat and cultured dairy more affordable and
More news about: MarketsandMarkets
Mar 26, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers - INO
development, and commercialization of DNA medicines to treat and protect people from diseases associated with, inter alia, human papilloma virus ("HPV"). The Company's DNA medicines are comprised of two components: (i) DNA plasmids, which are small circular DNA molecules that purportedly work like
More news about: Pomerantz LLP
Mar 26, 2026, 08:17 ET Volition Announces Abstract Demonstrating Risk Stratification in Lung Cancer Presented at the European Lung Cancer Conference
ELCC 2026Grolleau E, et al. Circulating H3K27 Methylated Nucleosome Plasma Concentration: Synergistic Information with Circulating Tumor DNA Molecular Profiling. Biomolecules. 2023;13(8):1255. https://doi.org/10.3390/biom13081255Couraud
More news about: VolitionRx Limited
Mar 26, 2026, 08:00 ET Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
EsoGuard® Esophageal DNA Tests in 4Q25.Recognized $1.5 million in EsoGuard revenue for 4Q25.Awarded
More news about: Lucid Diagnostics
Mar 26, 2026, 07:00 ET BioLineRx Announces Initiation of Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM)
GLIX1, a TET2 activator, is a first-in-class, oral, small molecule targeting DNA damage response in glioblastoma and other cancers GLIX1 has demonstrated potent anti-tumor activity in multiple
More news about: BioLineRx Ltd.
Mar 25, 2026, 10:00 ET Miraterra Soil raises $16 million in oversubscribed financing round
"Enabled by our new funding, the acquisition brings a pioneering U.S. soil biology company north, establishing Canada as a global hub for soil DNA sequencing and biological data innovation." Miraterra's mission aligns closely with the Government of Canada's prioritization of cleantech
More news about: Miraterra Technologies Corporation
Mar 25, 2026, 09:26 ET Texas Children's Researcher Awarded Grant to Advance New Ways to Prevent and Treat Alzheimer's Disease
leverages existing genomic data at an unprecedented scale – analyzing information that is often overlooked in traditional studies. By identifying viral DNA within these datasets, the research has the potential to uncover previously hidden connections between infection, genetics and disease that could not
More news about: Texas Children's Hospital
Mar 25, 2026, 08:17 ET Volition Announces Detection of Over 95% of Early-Stage Cancers
biopsy worldwide is that the vast majority of circulating DNA in blood plasma samples comes from healthy cells, not cancer cells. In a world first new technology, Volition has overcome this hurdle and produced >99% pure cancer derived plasma DNA sequence sets for liquid biopsy.In a recently submitted
More news about: VolitionRx Limited
Mar 25, 2026, 08:00 ET Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization
diagnostics technologies. The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform (subject to
More news about: Co-Diagnostics
Mar 25, 2026, 07:30 ET Bladex Outlines 2030 Strategy to Drive Sustainable Growth and Higher Returns at Investor Day
of the 2022–2026 plan, noting that Bladex met or exceeded its main financial and strategic objectives ahead of schedule while preserving its low–risk DNA. Between 2021 and 2025, the commercial portfolio grew 71%, lending spread expanded by 86 basis points, reserve coverage strengthened, the cost–to–income
More news about: Bladex